HGA, a leading design firm, has collaborated with Crinetics Pharmaceuticals to create new lab and office spaces within their headquarters in San Diego. The project includes 21,000 square feet of chemistry and biology laboratories spread across two floors. This expansion is part of Crinetics’ commitment to developing innovative treatments for endocrine diseases and tumors while accommodating their growing workforce.
The newly leased building at 6055 Lusk Blvd will serve as the company’s R&D hub starting in 2022. It features state-of-the-art medical, analytical, formulation chemistry labs along with support spaces such as tissue/cell culture areas and mass spectrometry facilities. HGA’s science + technology principal Trevor Wells expressed pride in being a part of this project that will have a significant impact on Crinetics’ research efforts.
The completed first phase marks the opening of the new headquarters which aims to foster collaboration among employees while providing flexibility for future growth. HGA worked closely with Crinetics to bring their vision to life by designing specialized lab facilities that catered specifically to their needs.
